Opening argument

AI can generate an analysis, interpret evidence, and recommend action in seconds. But when that recommendation influences a consequential GMP decision, the organization—not the system—must be able to explain why relying on it was reasonable.

For Quality Assurance and Compliance executives, “manufacturing intelligence” raises a question that speed alone cannot answer: who takes responsibility for turning a generated answer into an authorized decision?

The opportunity is substantial: produce useful analysis faster, reduce administrative effort, and give experienced people more time for difficult judgments. The challenge is to capture those benefits without allowing the appearance of intelligence to substitute for evidence.

  1. AI analysis Generates analysis, interpretation, and a recommendation.
  2. Human evaluation Tests the evidence, assumptions, and uncertainty behind it.
  3. Authorized decision An accountable person accepts reliance on the result. Accountability begins

When intelligence is cheap to generate, what makes it trustworthy enough to act on?

01 / The credibility question

An answer is not yet a basis for action

“Manufacturing intelligence” is a useful metaphor for producing analyses, interpretations, recommendations, and proposed actions at scale. But generating an answer is not the same as establishing that it is fit for a particular decision.

FDA’s draft guidance on AI supporting drug and biological-product regulatory decisions addresses this distinction through a risk-based credibility assessment for a defined context of use. The question is not simply whether a model performs well in general, but whether its credibility has been established for the purpose it is intended to serve. This remains draft guidance, not a blanket requirement governing every business use of AI.

For executives, that distinction changes the management question. “Can this system produce the report?” is only the beginning. The more consequential question is, “What must we establish before the business can rely on its conclusions?”

A practical framework is to examine the production chain behind the recommendation:

The production chain behind an AI-generated recommendation

  1. What went into it?

    Source evidence, relevance, completeness, and limitations

  2. How was it produced?

    The system, instructions, methods, and applicable version

  3. What supports its use?

    Testing and evidence appropriate to the intended decision

  4. Where can it fail?

    Assumptions, uncertainty, foreseeable errors, and consequences

  5. Who accepted it?

    The accountable person who authorized reliance on the result

  6. What changes require reassessment?

    New evidence or changes that could undermine the original basis for reliance

This is a proposed operating framework, not a list of newly established regulatory obligations. It provides a way to distinguish a useful output from a justified basis for action.

02 / The risk

The danger is manufacturing certainty

Consider an AI-assisted deviation investigation.

The system produces a persuasive summary, ranks possible causes, and recommends closure. The document is complete. The prose is confident. The workflow moves forward.

Yet the critical questions remain:

  • Did the analysis consider contradictory evidence?
  • Did it distinguish an observed fact from an inferred explanation?
  • Were its assumptions appropriate?
  • Were gaps in the investigation made visible?
  • Did the reviewer independently evaluate the recommendation—or merely approve the writing?

In this example, the risk is not confined to an obviously incorrect answer. It is also the possibility that an incomplete explanation becomes convincing enough to escape meaningful challenge.

That is not an entirely new quality problem. ICH Q9(R1) emphasizes managing subjectivity, addressing bias and assumptions, and using relevant data and knowledge. It also recognizes that revealing uncertainty helps establish the limitations of a risk assessment.

AI makes those disciplines particularly important when a polished assessment can be produced before the underlying uncertainty has been resolved.

03 / Responsibility

Quality Assurance and Compliance have complementary responsibilities

For QA, the practical focus is whether the evidence and evaluation support the proposed conclusion. A complete report is not enough if the underlying analysis is inadequate.

For Compliance, the corresponding focus is whether the organization’s use of that analysis follows applicable requirements and its own procedures: what reliance was permitted, what review was expected, and what authorization was necessary.

The precise division of responsibilities will depend on the company’s quality system. A useful common objective, however, is to make the transition from generated recommendation to organizational decision explicit.

In the deviation example, the decision record should make clear what the system contributed, what the reviewer verified, which uncertainties remained, and why closure was considered appropriate. An approval should communicate the scope of the judgment—not merely record that someone completed a workflow step.

Accountability becomes meaningful when another qualified person can understand what was evaluated and accepted.

The people who must evaluate, authorize, and explain the decision.

04 / Controlled speed

The business opportunity is controlled speed

The wrong response is to require the same exhaustive review for every AI-generated sentence. The equally wrong response is to treat a fluent answer as verified work.

A more useful management approach distinguishes three kinds of use:

Where generated intelligence becomes organizational action

  1. Assistance

    Organize and draft

    Organizing material, retrieving information, or preparing a draft.

  2. Recommendation

    Interpret and propose

    Interpreting evidence or proposing a course of action.

  3. Execution

    Change or initiate

    Changing a record, initiating an action, or affecting an outcome.

These are proposed management categories, not regulatory classifications. They help executives identify where stronger evidence, review, and authorization belong. The actual controls should reflect the intended use and the consequences of error.

The underlying principle is familiar: the effort, formality, and documentation of quality risk management should be proportionate to risk. ICH Q9(R1) also identifies uncertainty, importance, and complexity as considerations when determining the appropriate degree of formality.

For an executive, that means investing in controls where failure matters most, rather than choosing between unrestricted use and a review process that eliminates the productivity benefit.

Resource pressure does not justify weaker risk assessment. ICH Q9(R1) explicitly cautions against using resource constraints to justify lower levels of formality. The management opportunity is to allocate resources intelligently while preserving the rigor the decision requires.

05 / Continuity

Authorization is not the end of the story

A decision can be reasonable when made and still require reconsideration later.

New evidence may emerge. The system may change. The conditions under which a recommendation was tested may no longer match the conditions in which it is being used.

ICH Q9(R1) treats risk management as an ongoing process. It calls for reviewing results in light of new knowledge and experience, including events that may affect the original risk-management decision.

Applied to AI-assisted decisions, the practical implication is to preserve not only the original basis for reliance, but also the conditions that would prompt reassessment.

That makes the decision record useful beyond the moment of approval. It helps the organization determine whether an earlier judgment remains applicable—or whether the basis for it has changed.

06 / The ComplianceWorxs connection

Making the reasoning available—not just the result

The practical challenge is to preserve the basis for a decision while it is being made, rather than reconstruct it when an inspector, executive, or successor asks why it was reasonable.

That means connecting the evidence available at the time with the judgment exercised, the uncertainty that remained, the risk accepted, and the authority behind the action. This complements ICH Q9(R1)’s emphasis on evidence-based decisions, explicit assumptions, risk communication, and review as knowledge changes.

ComplianceWorxs approaches this through a connected body of executive analysis, worked Case Files, assessments, and practical decision-record tools. The editorial material examines how consequential Quality decisions come under scrutiny. The Case Files demonstrate the difference between documenting an outcome and preserving its justification.

The assessments help executives examine their own decisions, while the Inspection Response Record provides a structure for capturing the evidence, judgment, risk, and authorization behind a specific GMP decision.

Applied to AI-assisted work, that structure focuses attention on the point where generated intelligence becomes organizational reliance: what was verified, which limitations mattered, why proceeding was considered reasonable, and who accepted responsibility. It does not replace system validation, scientific evaluation, or qualified human judgment. It helps preserve the decision those activities support.

The objective is not another layer of paperwork. It is continuity: enabling someone who was not present when the decision was made to understand its basis without depending on the original participants’ memories.

A company may be able to generate an answer in seconds. Its ability to explain why it acted on that answer is what makes speed accountable.

Source context: FDA draft guidance on AI to support regulatory decision-making · ICH Q9(R1) Quality Risk Management. The production-chain framework and the assistance / recommendation / execution categories are CW editorial proposals, not regulatory requirements.